CA2752660A1 - Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient - Google Patents
Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient Download PDFInfo
- Publication number
- CA2752660A1 CA2752660A1 CA2752660A CA2752660A CA2752660A1 CA 2752660 A1 CA2752660 A1 CA 2752660A1 CA 2752660 A CA2752660 A CA 2752660A CA 2752660 A CA2752660 A CA 2752660A CA 2752660 A1 CA2752660 A1 CA 2752660A1
- Authority
- CA
- Canada
- Prior art keywords
- stent
- arches
- arch
- retaining
- positioning
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000002513 implantation Methods 0.000 title claims abstract description 91
- 238000004873 anchoring Methods 0.000 title claims abstract description 83
- 210000002216 heart Anatomy 0.000 title claims abstract description 70
- 210000003709 heart valve Anatomy 0.000 claims abstract description 274
- 238000011282 treatment Methods 0.000 claims abstract description 15
- 238000013461 design Methods 0.000 claims description 92
- 230000002792 vascular Effects 0.000 claims description 38
- 238000003780 insertion Methods 0.000 claims description 29
- 230000037431 insertion Effects 0.000 claims description 29
- 238000000034 method Methods 0.000 claims description 26
- 210000001765 aortic valve Anatomy 0.000 claims description 25
- 229910052751 metal Inorganic materials 0.000 claims description 21
- 239000002184 metal Substances 0.000 claims description 21
- 230000005012 migration Effects 0.000 claims description 16
- 238000013508 migration Methods 0.000 claims description 16
- 239000012781 shape memory material Substances 0.000 claims description 10
- 210000003516 pericardium Anatomy 0.000 claims description 7
- 230000036760 body temperature Effects 0.000 claims description 6
- 230000033001 locomotion Effects 0.000 abstract description 27
- 238000006073 displacement reaction Methods 0.000 abstract description 13
- 230000002572 peristaltic effect Effects 0.000 abstract description 12
- 238000005520 cutting process Methods 0.000 description 57
- 210000001519 tissue Anatomy 0.000 description 56
- 239000000463 material Substances 0.000 description 38
- 210000004204 blood vessel Anatomy 0.000 description 30
- 230000006870 function Effects 0.000 description 27
- 210000005240 left ventricle Anatomy 0.000 description 16
- 238000004519 manufacturing process Methods 0.000 description 16
- 230000006378 damage Effects 0.000 description 15
- 239000011324 bead Substances 0.000 description 14
- 239000008280 blood Substances 0.000 description 14
- 210000004369 blood Anatomy 0.000 description 14
- 210000003102 pulmonary valve Anatomy 0.000 description 13
- 210000001367 artery Anatomy 0.000 description 12
- 210000002837 heart atrium Anatomy 0.000 description 11
- 230000001419 dependent effect Effects 0.000 description 10
- 210000000709 aorta Anatomy 0.000 description 9
- 238000013459 approach Methods 0.000 description 9
- 230000008901 benefit Effects 0.000 description 9
- 230000017531 blood circulation Effects 0.000 description 9
- 239000007943 implant Substances 0.000 description 9
- 210000004115 mitral valve Anatomy 0.000 description 9
- 241001465754 Metazoa Species 0.000 description 8
- 238000005452 bending Methods 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 230000003446 memory effect Effects 0.000 description 8
- 208000031481 Pathologic Constriction Diseases 0.000 description 7
- 230000002441 reversible effect Effects 0.000 description 7
- 230000036262 stenosis Effects 0.000 description 7
- 208000037804 stenosis Diseases 0.000 description 7
- 230000002861 ventricular Effects 0.000 description 7
- 210000003484 anatomy Anatomy 0.000 description 6
- 206010002906 aortic stenosis Diseases 0.000 description 6
- 230000000747 cardiac effect Effects 0.000 description 6
- 208000003017 Aortic Valve Stenosis Diseases 0.000 description 5
- 208000027418 Wounds and injury Diseases 0.000 description 5
- 230000007547 defect Effects 0.000 description 5
- 208000014674 injury Diseases 0.000 description 5
- 210000005036 nerve Anatomy 0.000 description 5
- 229910001000 nickel titanium Inorganic materials 0.000 description 5
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 description 5
- 230000002829 reductive effect Effects 0.000 description 5
- 238000007789 sealing Methods 0.000 description 5
- 238000007493 shaping process Methods 0.000 description 5
- 238000001356 surgical procedure Methods 0.000 description 5
- 238000007669 thermal treatment Methods 0.000 description 5
- 201000002064 aortic valve insufficiency Diseases 0.000 description 4
- 238000011065 in-situ storage Methods 0.000 description 4
- 210000005246 left atrium Anatomy 0.000 description 4
- 210000003205 muscle Anatomy 0.000 description 4
- 210000004165 myocardium Anatomy 0.000 description 4
- 230000002093 peripheral effect Effects 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 210000001147 pulmonary artery Anatomy 0.000 description 4
- 210000000591 tricuspid valve Anatomy 0.000 description 4
- QNRATNLHPGXHMA-XZHTYLCXSA-N (r)-(6-ethoxyquinolin-4-yl)-[(2s,4s,5r)-5-ethyl-1-azabicyclo[2.2.2]octan-2-yl]methanol;hydrochloride Chemical compound Cl.C([C@H]([C@H](C1)CC)C2)CN1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OCC)C=C21 QNRATNLHPGXHMA-XZHTYLCXSA-N 0.000 description 3
- 241000283690 Bos taurus Species 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 230000008602 contraction Effects 0.000 description 3
- 239000002826 coolant Substances 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 239000004744 fabric Substances 0.000 description 3
- 208000028867 ischemia Diseases 0.000 description 3
- 208000005907 mitral valve insufficiency Diseases 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 230000002685 pulmonary effect Effects 0.000 description 3
- 230000000717 retained effect Effects 0.000 description 3
- 230000002966 stenotic effect Effects 0.000 description 3
- 229920002994 synthetic fiber Polymers 0.000 description 3
- 230000035488 systolic blood pressure Effects 0.000 description 3
- 230000007704 transition Effects 0.000 description 3
- 238000002604 ultrasonography Methods 0.000 description 3
- 206010002383 Angina Pectoris Diseases 0.000 description 2
- 206010002915 Aortic valve incompetence Diseases 0.000 description 2
- 206010003671 Atrioventricular Block Diseases 0.000 description 2
- 208000010271 Heart Block Diseases 0.000 description 2
- 206010020880 Hypertrophy Diseases 0.000 description 2
- 206010027727 Mitral valve incompetence Diseases 0.000 description 2
- 229910000990 Ni alloy Inorganic materials 0.000 description 2
- 206010067171 Regurgitation Diseases 0.000 description 2
- 229910001069 Ti alloy Inorganic materials 0.000 description 2
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 2
- WYTGDNHDOZPMIW-RCBQFDQVSA-N alstonine Natural products C1=CC2=C3C=CC=CC3=NC2=C2N1C[C@H]1[C@H](C)OC=C(C(=O)OC)[C@H]1C2 WYTGDNHDOZPMIW-RCBQFDQVSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 210000002376 aorta thoracic Anatomy 0.000 description 2
- 239000012620 biological material Substances 0.000 description 2
- 230000036770 blood supply Effects 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 208000016569 congenital mitral valve insufficiency Diseases 0.000 description 2
- 230000003205 diastolic effect Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000004064 dysfunction Effects 0.000 description 2
- 210000001105 femoral artery Anatomy 0.000 description 2
- 230000007849 functional defect Effects 0.000 description 2
- 238000011990 functional testing Methods 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 210000001624 hip Anatomy 0.000 description 2
- 238000007373 indentation Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 210000004379 membrane Anatomy 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 229920000728 polyester Polymers 0.000 description 2
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 2
- -1 polytetrafluoroethylenes Polymers 0.000 description 2
- 238000003825 pressing Methods 0.000 description 2
- 230000004088 pulmonary circulation Effects 0.000 description 2
- 210000003492 pulmonary vein Anatomy 0.000 description 2
- 210000005245 right atrium Anatomy 0.000 description 2
- 210000005241 right ventricle Anatomy 0.000 description 2
- 238000005096 rolling process Methods 0.000 description 2
- 230000007480 spreading Effects 0.000 description 2
- 238000003892 spreading Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 239000010936 titanium Substances 0.000 description 2
- 238000009827 uniform distribution Methods 0.000 description 2
- 210000002620 vena cava superior Anatomy 0.000 description 2
- 101800004637 Communis Proteins 0.000 description 1
- 229920004934 Dacron® Polymers 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 241000283073 Equus caballus Species 0.000 description 1
- 206010016803 Fluid overload Diseases 0.000 description 1
- 208000010496 Heart Arrest Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000007177 Left Ventricular Hypertrophy Diseases 0.000 description 1
- 241000289581 Macropus sp. Species 0.000 description 1
- 241000237509 Patinopecten sp. Species 0.000 description 1
- 206010037423 Pulmonary oedema Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 208000001122 Superior Vena Cava Syndrome Diseases 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 238000002583 angiography Methods 0.000 description 1
- 210000003157 atrial septum Anatomy 0.000 description 1
- 210000001992 atrioventricular node Anatomy 0.000 description 1
- 238000010009 beating Methods 0.000 description 1
- 210000004763 bicuspid Anatomy 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000002308 calcification Effects 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 238000005352 clarification Methods 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000002594 fluoroscopy Methods 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 208000018578 heart valve disease Diseases 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 210000003041 ligament Anatomy 0.000 description 1
- 238000002690 local anesthesia Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- 238000011369 optimal treatment Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 238000005498 polishing Methods 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 235000020637 scallop Nutrition 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000009958 sewing Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000003356 suture material Substances 0.000 description 1
- 230000001839 systemic circulation Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000008467 tissue growth Effects 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 210000001631 vena cava inferior Anatomy 0.000 description 1
- 210000000596 ventricular septum Anatomy 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
- 239000002759 woven fabric Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2412—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with soft flexible valve members, e.g. tissue valves shaped like natural valves
- A61F2/2418—Scaffolds therefor, e.g. support stents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0002—Two-dimensional shapes, e.g. cross-sections
- A61F2230/0017—Angular shapes
- A61F2230/0023—Angular shapes triangular
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Prostheses (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/EP2010/052429 WO2010086460A1 (en) | 2009-02-25 | 2010-02-25 | Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2752660A1 true CA2752660A1 (en) | 2010-08-05 |
Family
ID=44838288
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2752660A Abandoned CA2752660A1 (en) | 2010-02-25 | 2010-02-25 | Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient |
| CA2791090A Abandoned CA2791090A1 (en) | 2010-02-25 | 2011-02-23 | Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2791090A Abandoned CA2791090A1 (en) | 2010-02-25 | 2011-02-23 | Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient |
Country Status (5)
| Country | Link |
|---|---|
| JP (1) | JP5795009B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN102985033B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2011219865A1 (cg-RX-API-DMAC7.html) |
| CA (2) | CA2752660A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL221352A0 (cg-RX-API-DMAC7.html) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9414910B2 (en) | 2012-01-13 | 2016-08-16 | Assistance Publique—Hopitaux de Paris | Anchoring device for a prosthetic heart valve |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102005003632A1 (de) | 2005-01-20 | 2006-08-17 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Katheter für die transvaskuläre Implantation von Herzklappenprothesen |
| US7896915B2 (en) | 2007-04-13 | 2011-03-01 | Jenavalve Technology, Inc. | Medical device for treating a heart valve insufficiency |
| US9044318B2 (en) | 2008-02-26 | 2015-06-02 | Jenavalve Technology Gmbh | Stent for the positioning and anchoring of a valvular prosthesis |
| BR112012021347A2 (pt) | 2008-02-26 | 2019-09-24 | Jenavalve Tecnology Inc | stent para posicionamento e ancoragem de uma prótese valvular em um local de implantação no coração de um paciente |
| US10856978B2 (en) | 2010-05-20 | 2020-12-08 | Jenavalve Technology, Inc. | Catheter system |
| CN103002833B (zh) | 2010-05-25 | 2016-05-11 | 耶拿阀门科技公司 | 人工心脏瓣及包括人工心脏瓣和支架的经导管输送的内假体 |
| US9867694B2 (en) | 2013-08-30 | 2018-01-16 | Jenavalve Technology Inc. | Radially collapsible frame for a prosthetic valve and method for manufacturing such a frame |
| EP3256077B1 (en) * | 2015-02-13 | 2024-03-27 | Boston Scientific Scimed, Inc. | Valve replacement using rotational anchors |
| JP6829692B2 (ja) | 2015-03-20 | 2021-02-10 | イェーナヴァルヴ テクノロジー インコーポレイテッド | 心臓弁プロテーゼ送出システム及び導入体シースにより心臓弁プロテーゼを送出するための方法 |
| US10709555B2 (en) | 2015-05-01 | 2020-07-14 | Jenavalve Technology, Inc. | Device and method with reduced pacemaker rate in heart valve replacement |
| CN105125322B (zh) * | 2015-10-20 | 2017-03-29 | 宁波健世生物科技有限公司 | 一种新型的人工瓣膜假体 |
| CN109475419B (zh) | 2016-05-13 | 2021-11-09 | 耶拿阀门科技股份有限公司 | 用于通过引导鞘和装载系统来递送心脏瓣膜假体的心脏瓣膜假体递送系统和方法 |
| US10653523B2 (en) * | 2017-01-19 | 2020-05-19 | 4C Medical Technologies, Inc. | Systems, methods and devices for delivery systems, methods and devices for implanting prosthetic heart valves |
| US10561495B2 (en) | 2017-01-24 | 2020-02-18 | 4C Medical Technologies, Inc. | Systems, methods and devices for two-step delivery and implantation of prosthetic heart valve |
| WO2018138658A1 (en) | 2017-01-27 | 2018-08-02 | Jenavalve Technology, Inc. | Heart valve mimicry |
| US12029647B2 (en) | 2017-03-07 | 2024-07-09 | 4C Medical Technologies, Inc. | Systems, methods and devices for prosthetic heart valve with single valve leaflet |
| US12036113B2 (en) | 2017-06-14 | 2024-07-16 | 4C Medical Technologies, Inc. | Delivery of heart chamber prosthetic valve implant |
| CN107212950B (zh) * | 2017-07-12 | 2019-10-18 | 宁波健世生物科技有限公司 | 一种带夹持装置的心脏瓣膜假体 |
| CN110731836B (zh) * | 2018-07-20 | 2021-10-12 | 先健科技(深圳)有限公司 | 心脏瓣膜 |
| US11857441B2 (en) | 2018-09-04 | 2024-01-02 | 4C Medical Technologies, Inc. | Stent loading device |
| US11452628B2 (en) | 2019-04-15 | 2022-09-27 | 4C Medical Technologies, Inc. | Loading systems for collapsible prosthetic heart valve devices and methods thereof |
| CN111110402B (zh) * | 2020-01-09 | 2020-11-06 | 南京圣德医疗科技有限公司 | 一种结构贴合的经导管主动脉瓣膜植入装置 |
| US12133797B2 (en) | 2020-01-31 | 2024-11-05 | 4C Medical Technologies, Inc. | Prosthetic heart valve delivery system: paddle attachment feature |
| US11931253B2 (en) | 2020-01-31 | 2024-03-19 | 4C Medical Technologies, Inc. | Prosthetic heart valve delivery system: ball-slide attachment |
| US12053375B2 (en) | 2020-03-05 | 2024-08-06 | 4C Medical Technologies, Inc. | Prosthetic mitral valve with improved atrial and/or annular apposition and paravalvular leakage mitigation |
| US11992403B2 (en) | 2020-03-06 | 2024-05-28 | 4C Medical Technologies, Inc. | Devices, systems and methods for improving recapture of prosthetic heart valve device with stent frame having valve support with inwardly stent cells |
| WO2023184639A1 (zh) * | 2022-03-28 | 2023-10-05 | 科凯(南通)生命科学有限公司 | 抗反流心脏瓣膜支架 |
| WO2023185169A1 (zh) * | 2022-03-28 | 2023-10-05 | 科凯(南通)生命科学有限公司 | 一种瓣膜假体 |
| JP2025538294A (ja) | 2022-11-09 | 2025-11-27 | イエナバルブ テクノロジー インク | 拡張可能なインプラントの順次展開のためのカテーテルシステム |
| CN119454294B (zh) * | 2023-08-09 | 2025-09-30 | 科凯(南通)生命科学有限公司 | 反流瓣膜支架 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4403183B2 (ja) * | 2004-02-05 | 2010-01-20 | チルドレンズ・メディカル・センター・コーポレイション | 置換心臓弁の経カテーテル送達 |
| US8052750B2 (en) * | 2006-09-19 | 2011-11-08 | Medtronic Ventor Technologies Ltd | Valve prosthesis fixation techniques using sandwiching |
| CN101742975B (zh) * | 2007-04-13 | 2013-03-06 | 耶拿阀门科技公司 | 用于治疗心脏瓣膜关闭不全或狭窄的医疗装置 |
| EP2698129B1 (en) * | 2007-06-04 | 2022-11-09 | St. Jude Medical, LLC | Prosthetic heart valve |
| JP5203470B2 (ja) * | 2008-02-26 | 2013-06-05 | イエナバルブ テクノロジー インク | 患者の心臓の移植部位で弁プロテーゼを位置決めし固定するためのステント |
| US8317858B2 (en) * | 2008-02-26 | 2012-11-27 | Jenavalve Technology, Inc. | Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient |
| CN102413793B (zh) * | 2009-02-25 | 2015-01-28 | 耶拿阀门科技公司 | 用于瓣膜假体在病人心脏中的植入部位的定位和锚定的支架 |
-
2010
- 2010-02-25 CA CA2752660A patent/CA2752660A1/en not_active Abandoned
-
2011
- 2011-02-23 AU AU2011219865A patent/AU2011219865A1/en not_active Abandoned
- 2011-02-23 JP JP2012554334A patent/JP5795009B2/ja active Active
- 2011-02-23 CA CA2791090A patent/CA2791090A1/en not_active Abandoned
- 2011-02-23 CN CN201180020832.4A patent/CN102985033B/zh active Active
-
2012
- 2012-08-08 IL IL221352A patent/IL221352A0/en unknown
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9414910B2 (en) | 2012-01-13 | 2016-08-16 | Assistance Publique—Hopitaux de Paris | Anchoring device for a prosthetic heart valve |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2013520260A (ja) | 2013-06-06 |
| IL221352A0 (en) | 2012-10-31 |
| CN102985033B (zh) | 2015-08-12 |
| CA2791090A1 (en) | 2011-09-01 |
| CN102985033A (zh) | 2013-03-20 |
| JP5795009B2 (ja) | 2015-10-14 |
| AU2011219865A1 (en) | 2012-08-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11154398B2 (en) | Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient | |
| EP2400923B1 (en) | Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient | |
| US8398704B2 (en) | Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient | |
| US8790395B2 (en) | Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient | |
| EP2617390B1 (en) | Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient | |
| US9707075B2 (en) | Endoprosthesis for implantation in the heart of a patient | |
| US9265631B2 (en) | Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient | |
| EP2538878B1 (en) | Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient | |
| CA2752660A1 (en) | Stent for the positioning and anchoring of a valvular prosthesis in an implantation site in the heart of a patient |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued |
Effective date: 20160225 |